Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 16/20 | 1.00 |
| ▸ | CNR1 | P21554 | 14/20 | 1.00 |
| ▸ | TRPM8 | Q7Z2W7 | 2/20 | 1.00 |
| ▸ | GPR55 | Q9Y2T6 | 2/20 | 1.00 |
| ▸ | TRPA1 | O75762 | 1/20 | 1.00 |
| ▸ | HTR1A | P08908 | 1/20 | 1.00 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 1.00 |
| ▸ | TRPV3 | Q8NET8 | 1/20 | 1.00 |
| ▸ | TRPV6 | Q9H1D0 | 1/20 | 1.00 |
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 1.00 |
| ▸ | TRPV5 | Q9NQA5 | 1/20 | 1.00 |
| ▸ | TRPV2 | Q9Y5S1 | 1/20 | 1.00 |
| ▸ | ABHD12 | Q8N2K0 | 3/20 | 0.86 |
| ▸ | ABHD6 | Q9BV23 | 3/20 | 0.86 |
| ▸ | FAAH | O00519 | 2/20 | 0.86 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.86 |
| ▸ | LDHA | P00338 | 1/20 | 0.86 |
| ▸ | GLRA1 | P23415 | 1/20 | 0.86 |
| ▸ | GPR183 | P32249 | 1/20 | 0.86 |
| ▸ | DRD3 | P35462 | 1/20 | 0.86 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tetrahydrocannabivarin SCHEMBL29904669 | 1.00 | CNR2 (1.00) | CNR2CNR1TRPM8GPR55TRPA1 | |
| Tetrahydrocannabivarin SCHEMBL29422123 | 1.00 | CNR2 (1.00) | CNR2CNR1TRPM8GPR55TRPA1 | |
| Tetrahydrocannabivarin SCHEMBL30017852 | 1.00 | CNR2 (1.00) | CNR2CNR1TRPM8GPR55TRPA1 | |
| Tetrahydrocannabivarin SCHEMBL31300003 | 1.00 | CNR2 (1.00) | CNR2CNR1TRPM8GPR55TRPA1 | |
| Tetrahydrocannabivarin SCHEMBL31544930 | 1.00 | CNR2 (1.00) | CNR2CNR1TRPM8GPR55TRPA1 | |
| Tetrahydrocannabivarin SCHEMBL18371743 | 1.00 | CNR2 (1.00) | CNR2CNR1TRPM8GPR55TRPA1 | |
| Tetrahydrocannabivarin SCHEMBL29350511 | 1.00 | CNR2 (1.00) | CNR2CNR1TRPM8GPR55TRPA1 | |
| Tetrahydrocannabivarin SCHEMBL6856739 | 1.00 | CNR2 (1.00) | CNR2CNR1TRPM8GPR55TRPA1 | |
| Tetrahydrocannabivarin SCHEMBL21363566 | 1.00 | CNR2 (1.00) | CNR2CNR1TRPM8GPR55TRPA1 | |
| Tetrahydrocannabivarin SCHEMBL25731794 | 1.00 | CNR2 (1.00) | CNR2CNR1TRPM8GPR55TRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 9593 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4412609-B1 | ALKOXYLATION OF CANNABIDIOL & OTHER CANNABINOIDS | INDORAMA VENTURES OXIDES LLC (US) | 2026-05-27 | — | — | EP | claimed |
| US-12636251-B1 | Glycoside-containing aqueous formulations having a lipophilic active component | Doane Technology Group LLC (US) | 2026-05-26 | — | — | US | claimed |
| US-12629332-B2 | Cannabinoid chewing gum with sugar alcohols | NORDICCAN A/S (DK) | 2026-05-19 | — | — | US | claimed |
| EP-4739284-A1 | AN ADHESIVE ORAL DISC FOR SUSTAINED RELEASE OF CANNABINOIDS | Fertin Pharma A/S (DK) | 2026-05-13 | — | — | EP | claimed |
| EP-4291170-B1 | USE OF CANNABIDIVARIN IN THE TREATMENT OF SEIZURES ASSOCIATED WITH CANINE EPILEPSY | JAZZ PHARMACEUTICALS RESEARCH UK LTD (GB) | 2026-05-13 | — | — | EP | claimed |
| EP-4740961-A2 | CANNABINOID PRODUCT FOR IMPROVING MUSCULOSKELETAL HEALTH | Lonza Greenwood LLC (US) | 2026-05-13 | — | — | EP | claimed |
| EP-4734974-A1 | CANNABINOID COMPOSITION FOR USE IN THE TREATMENT OF PAIN AND/OR INFLAMMATION | Mabewo Phytopharm AG (CH) | 2026-05-06 | — | — | EP | claimed |
| US-12616728-B2 | Processes and systems for converting cannabinoids into cannabinoid derivatives and isolating the same | SUPER CRITICAL IP, LLC (US) | 2026-05-05 | — | — | US | claimed |
| EP-4037503-B1 | CANNABINOID PRODUCT FOR IMPROVING MUSCULOSKELETAL HEALTH | LONZA GREENWOOD LLC (US) | 2026-04-29 | — | — | EP | claimed |
| US-12611446-B2 | Cannabinoid product for improving musculoskeletal health | LONZA GREENWOOD LLC (US) | 2026-04-28 | — | — | US | claimed |
| US-20110082195-A1 | NEW USE FOR CANNABINOIDS | GW PHARMA LIMITED (GB) | 2011-04-07 | — | — | US | claimed |
| EP-2283832-A1 | Compositions comprising cannabinoids for treatment of nausea, vomiting, emesis, motion sickness or like conditions | GW Pharma Limited (GB) | 2011-02-16 | — | — | EP | claimed |
| WO-2011001169-A1 | USE OF ONE OR A COMBINATION OF PHYTO-CANNABINOIDS IN THE TREATMENT OF EPILEPSY | GW PHARMA LIMITED (GB) | 2011-01-06 | — | — | WO | claimed |
| EP-2161262-A1 | THCV and THCV extracts derived from plant material | GW Pharma Limited (GB) | 2010-03-10 | — | — | EP | claimed |
| WO-2010013240-A1 | COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY DISORDERS | DEKEL PHARMACEUTICALS LTD. (IL) | 2010-02-04 | — | — | WO | claimed |
| US-20070077660-A1 | Method for the detection of a cannabinoid, detection kit, and developing solvent | GLAS RONALD J | 2007-04-05 | — | — | US | claimed |
| EP-1542984-A2 | METHODS OF PURIFYING CANNABINOIDS FROM PLANT MATERIAL | GW Pharma Limited (GB) | 2005-06-22 | — | — | EP | claimed |
| WO-2004026857-A2 | METHODS OF PURIFYING CANNABINOIDS FROM PLANT MATERIAL | GW PHARMA LIMITED (GB) | 2004-04-01 | — | — | WO | claimed |
| EP-1109533-A1 | PULMONARY DELIVERY OF LIPOSOME-ENCAPSULATED CANNABINOIDS | Hung, Orlando (CA) | 2001-06-27 | — | — | EP | claimed |
| WO-2001003668-A1 | PULMONARY DELIVERY OF LIPOSOME-ENCAPSULATED CANNABINOIDS | HER MAJESTY THE QUEEN AS REPRESENTED BY THE MINISTER OF NATIONAL DEFENCE OF HER MAJESTY'S CANADIAN GOVERNMENT (CA) | 2001-01-18 | — | — | WO | claimed |